With the establishment of the contribution of TH signaling to AMD pathogenesis, inhibiting TH signaling locally in the retina, such as through the use of Dio2 inhibitors or TH receptor antagonists, might be a strategy for the management of AMD. This evidence concerns the gene DIO2 and age-related macular degeneration.